| Literature DB >> 35911260 |
G J Pavithira1, Souradeep Dutta1, Sudharsanan Sundaramurthi1, Vishnu Prasad Nelamangala Ramakrishnaiah1.
Abstract
Background Abdominal wall hernias are a common surgical entity encountered by the general surgeon. Approximately 10% of abdominal wall hernia patients require emergency surgery. However, these surgeries are associated with a high rate of postoperative morbidity and mortality. This study aimed to analyze the morbidity and mortality in patients undergoing emergency abdominal wall hernia repair and to determine the factors associated with surgical site infection (SSI) and recurrence in these patients attending a tertiary care hospital in south India. Methodology Our study was a single-centered, 10-year retrospective and a one-year prospective study conducted in a tertiary care center in India. All patients who underwent emergency abdominal wall hernia repair between April 2009 and May 2020 were included. Patients' demographic details, comorbidities, intraoperative findings, 30-day surgical outcomes including SSI, and recurrence were studied. Results Out of 383 patients in our study, 63.9% had an inguinal hernia, and 54% of the patients underwent tissue repair. SSI was the most common morbidity (21.9%). Postoperative sepsis was the only independent factor associated with perioperative mortality according to the logistic regression analysis (odds ratio = 22.73, p = 0.022). Conclusions Tissue repair for emergency hernia surgery has better outcomes than mesh repair in clean-contaminated cases.Entities:
Keywords: abdomen ventral hernia; emergency hernia repair; femoral hernia; hernia repair; inguinal hernia
Year: 2022 PMID: 35911260 PMCID: PMC9311230 DOI: 10.7759/cureus.26324
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Types of emergency hernia repair.
Comparison of comorbidities in the tissue repair group and mesh group.
*Chi-square test; #Fischer test; ^ BPH proportion in male patients; †Total number of patients mentioned in each group exceeds the actual number as more than one comorbidity was present in the same patient.
CAD/CCF: coronary artery disease/congestive cardiac failure; COPD: chronic obstructive pulmonary disease; BPH: benign prostatic hyperplasia; TB: tuberculosis
| Comorbidities | Total (n = 383*) | Tissue repair group (n = 207†) | Mesh group (n = 176†) | P-value* |
| Hypertension | 86 (22.5) | 52 (25.1) | 34 (19.3) | 0.175 |
| CAD/CCF | 23 (6) | 18 (8.7) | 5 (2.8) | 0.016 |
| Chronic liver disease | 11 (2.9) | 9 (4.3) | 2 (1.1) | 0.061 |
| Chronic kidney disease | 10 (2.6) | 6 (2.9) | 4 (2.3) | 0.757# |
| COPD | 12 (3.1) | 6 (2.9) | 6 (3.4) | 0.775 |
| Smoking | 59 (15.4) | 39 (18.8) | 20 (11.4) | 0.043 |
| BPH^ | 56 (20.3) | 30 (20.8) | 2 (20.6) | 0.946 |
| History of pulmonary TB | 11 (2.9) | 7 (3.4) | 4 (2.3) | 0.476 |
| Diabetes mellitus | 44 (11.5) | 30 (14.5) | 14 (8) | 0.046 |
| Asthma | 9 (2.3) | 6 (2.9) | 3 (1.7) | 0.516# |
| Steroid use | 20 (5.2) | 13 (6.3) | 7 (4) | 0.313 |
| Cancer | 9 (2.3) | 2 (1) | 7 (4) | 0.086# |
| Immunocompromised state± | 82 (21.4) | 52 (19.8) | 24 (11.9) | 0.037 |
| Past abdominal surgeries | 87 (22.7) | 42 (20.3) | 45 (25.6) | 0.219 |
| Past ventral hernia repair | 25 (6.5) | 15 (7.2) | 10 (5.7) | 0.537 |
| Past mesh repair | 10 (2.6) | 4 (1.9) | 6 (3.4) | 0.663 |
Comparison of perioperative variables in the mesh and tissue repair groups.
*Chi-square test; † Mann-Whitney U test; # Fisher’s exact test.
ASA: American Society of Anesthesiologists physical status classification system; IQR: interquartile range
| Preoperative variables | Tissue repair group (n = 207) | Mesh group (n = 176) | Total (n = 383) | P-value* |
| Presence of signs of peritonitis | 27 (13.04) | 4 (2.3) | 31 (8.1) | <0.001 |
| Presence of ascites | 21 (10.1) | 5 (2.8) | 26 (6.8) | 0.005 |
| ASA grade | ||||
| I | 74 (35.7) | 86 (48.9) | 160 (41.8) | 0.009 |
| II | 70 (33.8) | 59 (33.5) | 129 (33.7) | 0.952 |
| III | 48 (23.2) | 28 (15.9) | 76 (19.7) | 0.075 |
| IV | 15 (7.2) | 3 (1.7) | 18 (4.7) | 0.011 |
| Surgery duration in minutes (IQR) | 120 (90–150) | 105 (60–120) | - | 0.029† |
| Size of the defect in cm (IQR) | 2.4 (2–3) | 2.2 (1.9–4) | 2.4 (2–3) | 0.734† |
| Hernia complication | ||||
| Irreducible | 56 (27.1) | 83 (47.2) | 139 (36.3) | <0.001 |
| Obstructed | 72 (34.8) | 72 (40.9) | 144 (37.6) | 0.217 |
| Strangulated | 76 (36.7) | 20 (11.4) | 96 (25.1) | <0.001 |
| Eviscerated | 3 (1.4) | 1 (0.6) | 4 (1) | 0.628# |
| Sac content | ||||
| Small bowel | 111 (53.6) | 72 (40.9) | 183 (47.8) | 0.013 |
| Large bowel | 17 (8.2) | 26 (14.8) | 43 (11.2) | 0.043 |
| Small and large bowel | 15 (7.2) | 4 (2.3) | 19 (5) | 0.025 |
| Omentum | 36 (17.4) | 41 (23.3) | 77 (20.1) | 0.151 |
| Preperitoneal fat | 8 (3.9) | 1 (0.6) | 9 (2.3) | 0.042# |
| Appendix | 2 (1) | 3 (1.7) | 5 (1.3) | 0.665# |
| Bladder | 3 (1.4) | 0 (0) | 3 (0.8) | 0.253# |
| None | 15 (7.2) | 29 (16.5) | 44 (11.5) | 0.005 |
| Reactive fluid | 48 (23.2) | 28 (15.9) | 76 (19.8) | 0.075 |
Comparison of hernia variables and bowel characteristics in mesh and tissue repair groups
* Chi-square test.
| Nature of bowel | Tissue repair group (n = 145) | Mesh group (n = 105) | Total (n = 250) | P-value* |
| Normal | 54 (37.2) | 90 (85.7) | 144 (57.6) | <0.001 |
| Congested | 18 (12.4) | 6 (5.7) | 24 (9.6) | 0.033 |
| Pre-gangrenous | 6 (4.1) | 0 (0) | 6 (2.4) | 0.033 |
| Patchy gangrenous | 6 (4.1) | 0 (0) | 6 (2.4) | 0.033 |
| Gangrenous | 61 (42) | 9 (8.6) | 70 (28) | <0.001 |
| Bowel resected | 64 (44.1) | 5 (4.7) | 69 (27.6) | - |
| None | 81 (55.8) | 100 (95.2) | 181 (72.4) | <0.001 |
| Small bowel | 57 (39.3) | 4 (3.8) | 61 (2.4) | <0.001 |
| Large bowel | 3 (2.1) | 0 (0) | 3 (1.2) | 0.253 |
| Both small and large bowel | 3 (2.1) | 1 (1) | 4 (1.6) | 0.628 |
| Appendix | 1 (0.7) | 0 (0) | 1 (0.4) | 0.391 |
Comparison of postoperative complications in the mesh and tissue repair groups.
# Fisher’s exact test; † Mann-Whitney U test; * Chi-square test.
ICU: intensive care unit; IQR: interquartile range; LRTI: lower respiratory tract infection; VAP: ventilator-associated pneumonia
| Postoperative complications | Tissue repair group (n = 207) | Mesh group (n = 176) | Total (n = 383) | P-value* |
| Surgical site infection | 53 (26.1) | 30 (17) | 83 (21.9) | 0.033 |
| Pulmonary complications | 30 (14.5) | 15 (8.5) | 45 (11.7) | 0.117 |
| LRTI | 7 | 5 | 12 | 0.762 |
| Atelectasis | 16 | 7 | 23 | 0.123 |
| Pleural effusion | 5 | 2 | 7 | 0.352 |
| VAP | 2 | 1 | 3 | 1.000 |
| Ileus | 12 (5.8) | 5 (2.8) | 17 (4.4) | 0.162 |
| Postoperative fistula | 1 (0.5) | 1 (0.6) | 2 (0.5) | 1.000 |
| Urinary tract infection | 9 (4.3) | 4 (2.3) | 13 (3.4) | 0.264 |
| Cardiac complications | 5 (2.4) | 6 (3.4) | 11 (2.9) | 0.562 |
| Renal failure requiring dialysis | 3 (1.4) | 2 (1.1) | 5 (1.3) | 1.000 |
| Liver failure | 3 (1.4) | 1 (0.6) | 4 (1) | 0.628 |
| Seroma | 2 (1) | 2 (1.1) | 4 (1) | 1.000 |
| Presence of sepsis | 9 (4.3) | 1 (0.6) | 10 (2.6) | 0.024# |
| Days of ICU stay median (IQR) | 2 (2–3) | 1.5 (1–2) | 2 (1–3) | 0.009† |
| Days of hospital stay median (IQR) | 8 (5–11) | 6 (4–9) | 7 (5–10) | 0.006† |
| 30-day re-admission (%) | 1 (0.5) | 1 (0.6) | 2 (0.5) | 1.000# |
| Reoperation (%) | 5 (2.4) | 5 (2.8) | 10 (2.6) | 1.000# |
| Mortality | 4 (1.9) | 2 (1.1) | 6 (1.6) | 0.528 |
Association between CDC wound classification and surgical site infection between the tissue and mesh repair groups
* Chi-square test; # Fisher’s exact test.
CDC: Centers for Disease Control and Prevention; SSI: surgical site infection
| CDC classification | SSI | Tissue repair (n = 207) | Mesh repair (n = 176) | P-value* |
| Class 1: Clean | Present | 17 (8.2) | 20 (11.4) | 0.537 |
| Absent | 72 (34.8) | 106 (60.2) | ||
| Total | 89 (43) | 126 (71.6) | <0.001 | |
| Class II: Clean- contaminated | Present | 17 (8.2) | 8 (4.5) | 0.570 |
| Absent | 60 (28.9) | 37 (21) | ||
| Total | 77 (37.2) | 45 (25.6) | 0.015 | |
| Class III: Contaminated | Present | 9 (4.3) | 0 (0) | 0.268# |
| Absent | 14 (6.8) | 4 (2.3) | ||
| Total | 23 (11.1) | 4 (2.3) | 0.001 | |
| Class IV: Dirty infected | Present | 11 (5.3) | 0 (0) | 1.000# |
| Absent | 7 (3.4) | 1 (0.6) | ||
| Total | 18 (8.7) | 1 (0.6) | <0.001 |
Association factors for perioperative SSI and perioperative mortality in abdominal hernia repair patients.
CDC: Centers for Disease Control and Prevention; SSI: surgical site infection
| Perioperative SSI | Perioperative mortality | |||||
| Parameters | Present (n = 83) | Absent (n = 300) | P-value | Present (n = 6) | Absent (n = 377) | P-value |
| Diabetes mellitus (n = 44) | 16 (19.2) | 28 (9.3) | 0.014 | - | - | - |
| Past abdominal surgery (n = 87) | 27 (32.5) | 60 (20) | 0.020 | - | - | - |
| Surgery duration >2 hours (n = 104) | 40 (48.2) | 64 (21.3) | 0.000 | - | - | - |
| CDC classification | - | - | - | |||
| Clean class I (n = 215) | 37 (44.6) | 178(59.3) | 0.017 | - | - | - |
| Dirty class IV (n = 19) | 12 (14.4) | 7 (2.3) | <0.001 | - | - | - |
| Presence of peritonitis (n = 31) | 13 (15.6) | 18 (6) | 0.005 | 3 (50) | 28 (7.4) | 0.008 |
| Presence of ascites (n = 26) | 11 (13.2) | 15 (5) | 0.009 | 2 (33.3) | 24 (6.3) | 0.056 |
| Bowel resection (n = 69) | 27 (32.5) | 42 (14) | 0.000 | 4 (66.7) | 65 (17.2) | 0.022 |
| Drain placement (n = 113) | - | - | - | 5 (83.3) | 108 (28.6) | 0.011 |
| Re-exploration(n = 10) | - | - | - | 2 (33.3) | 8 (2.1) | 0.009 |
| Postoperative pulmonary complication (n = 45) | - | - | - | 4 (66.7) | 41 (10.9) | 0.003 |
| Postoperative Sepsis (n = 10) | - | - | - | 4 (66.7) | 6 (1.6) | <0.001 |
Figure 2The Kaplan-Meier plot of recurrence after abdominal wall hernia repair.